Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review
Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More
-
Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)
Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC) Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases There are currently ten actionable genomic alterations (AGAs) that are addressed by ... Read More
-
Bio/Pharmaceutical Outsourcing Report, March 2025
Bio/Pharmaceutical Outsourcing Report, March 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing co ... Read More
-
Pulmonary Fibrosis - Global Clinical Trials Review, 2025
Pulmonary Fibrosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Pulmonary Fibrosis - Global Clinical Trials Review, 2025 provides an overview of Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pu ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025
Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025 provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report pro ... Read More
-
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025 provides an overview of Squamous Non-Small Cell Lung Cancer Clinical trials scenario. This report provides ... Read More
-
Meningitis - Global Clinical Trials Review, 2025
Meningitis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Meningitis - Global Clinical Trials Review, 2025 provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report include ... Read More
-
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 provides an overview of Actinic (Solar) Keratosis Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 provides an overview of Acute Decompensated Heart Failure Clinical trials scenario. This report provides top li ... Read More
-
Tuberculosis - Global Clinical Trials Review, 2025
Tuberculosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Tuberculosis - Global Clinical Trials Review, 2025 provides an overview of Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report ... Read More
-
China Biologic Products Holdings Inc - Strategic SWOT Analysis Review
China Biologic Products Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo ... Read More
-
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review
Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More
-
RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review
RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Malaria - Global Clinical Trials Review, 2025
Malaria - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2025 provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overvie ... Read More
-
Emerging Market Outsourcing Report - Q1 2025
Emerging Market Outsourcing Report - Q1 2025 Summary This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q1 2025, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identificatio ... Read More
-
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 provides an overview of Erythrodermic Psoriasis Clinical trials scenario. This report provides top line data relating to the clinic ... Read More
-
Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025
Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025 provides an overview of Type 1 Diabetes (Juvenile Diabetes) Clinical trials scenario. This report provides ... Read More
-
Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025
Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025 Summary Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG, is a pharmaceutical company that develops, manufactures and markets pharmaceuticals, parasiticides, vaccines and therapeutics for u ... Read More
-
Strategic Intelligence: The Future of Work in Healthcare
Strategic Intelligence: The Future of Work in Healthcare Summary AI will transform work in healthcare Artificial intelligence (AI) is reshaping all aspects of healthcare, from R&D in pharma to direct patient care. AI has transformed the drug discovery process by streamlining research and reducing th ... Read More
-
Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review
Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More
-
Emcure Pharmaceuticals Ltd (EMCURE) - Financial and Strategic SWOT Analysis Review
Emcure Pharmaceuticals Ltd (EMCURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Drug Development Trends in South Korea
Drug Development Trends in South Korea Summary South Korea has become a significant player in the global pharmaceutical industry and drug development space, fueled by its advanced healthcare system, growing pharmaceutical sector, strong research infrastructure, and government-backed initiatives to s ... Read More
-
Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review
Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ ... Read More
-
Laboratoires Thea SA - Strategic SWOT Analysis Review
Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s ... Read More
-
Chong Kun Dang Pharmaceutical Corp. (185750) - Financial and Strategic SWOT Analysis Review
Chong Kun Dang Pharmaceutical Corp. (185750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren ... Read More